Jonathan Jay Mazelsky - 14 Feb 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President & CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
14 Feb 2023
Net transactions value
-$834,548
Form type
4
Filing time
16 Feb 2023, 17:52:34 UTC
Previous filing
10 Feb 2023
Next filing
05 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +504 +0.71% $0.000000 71,327 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +435 +0.61% $0.000000 71,762 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +974 +1.4% $0.000000 72,736 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +689 +0.95% $0.000000 73,425 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +959 +1.3% $0.000000 74,384 14 Feb 2023 Direct
transaction IDXX Common Stock Tax liability $834,548 -1,657 -2.2% $503.65 72,727 14 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -504 -3.5% 13,884 14 Feb 2023 Common Stock 504 Direct F1, F6
transaction IDXX Restricted Stock Unit Options Exercise -435 -3.1% 13,449 14 Feb 2023 Common Stock 435 Direct F2, F6
transaction IDXX Restricted Stock Unit Options Exercise -974 -7.2% 12,475 14 Feb 2023 Common Stock 974 Direct F3, F6
transaction IDXX Restricted Stock Unit Options Exercise -689 -5.5% 11,786 14 Feb 2023 Common Stock 689 Direct F4, F6
transaction IDXX Restricted Stock Unit Options Exercise -959 -8.1% 10,827 14 Feb 2023 Common Stock 959 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F3 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F6 Not applicable.